Anúncio
Anúncio

LFST

LFST logo

LifeStance Health Group, Inc. Common Stock

7.30
USD
Patrocinado
+0.02
+0.32%
07 de jan., 16:00 UTC -5
Encerrado
exchange

Pós-Mercado

7.30

0.00
+0.03%

Relatórios de Lucros LFST

Rácio de surpresa positiva

LFST separação 10 de 18 últimas estimativas.

56%

Próximo Relatório

Data do Próximo Relatório
26 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$385.60M
/
$0.00
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+5.99%
/
--
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+18.47%
/
-100.00%

LifeStance Health Group, Inc. Common Stock earnings per share and revenue

On 06 de nov. de 2025, LFST reported earnings of 0.00 USD per share (EPS) for Q3 25, beating the estimate of -0.01 USD, resulting in a 100.00% surprise. Revenue reached 363.81 milhão, compared to an expected 362.72 milhão, with a 0.30% difference. The market reacted with a +29.94% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 analistas forecast an EPS of 0.00 USD, with revenue projected to reach 385.60 milhão USD, implying an aumentar of 0.00% EPS, and aumentar of 5.99% in Revenue from the last quarter.
FAQ
For Q3 2025, LifeStance Health Group, Inc. Common Stock reported EPS of $0.00, beating estimates by 100%, and revenue of $363.81M, 0.3% above expectations.
The stock price moved up 29.94%, changed from $4.81 before the earnings release to $6.25 the day after.
The next earning report is scheduled for 26 de fev. de 2026.
Based on 11 analistas, LifeStance Health Group, Inc. Common Stock is expected to report EPS of -- and revenue of $385.60M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio